Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons
Open Access
- 25 October 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (44)
Abstract
Inter-organelle contact sites between mitochondria and lysosomes mediate the crosstalk and bidirectional regulation of their dynamics in health and disease. However, mitochondria–lysosome contact sites and their misregulation have not been investigated in peripheral sensory neurons. Charcot–Marie–Tooth type 2B disease is an autosomal dominant axonal neuropathy affecting peripheral sensory neurons caused by mutations in the GTPase Rab7. Using live super-resolution and confocal time-lapse microscopy, we showed that mitochondria–lysosome contact sites dynamically form in the soma and axons of peripheral sensory neurons. Interestingly, Charcot–Marie–Tooth type 2B mutant Rab7 led to prolonged mitochondria–lysosome contact site tethering preferentially in the axons of peripheral sensory neurons, due to impaired Rab7 GTP hydrolysis–mediated contact site untethering. We further generated a Charcot–Marie–Tooth type 2B mutant Rab7 knock-in mouse model which exhibited prolonged axonal mitochondria–lysosome contact site tethering and defective downstream axonal mitochondrial dynamics due to impaired Rab7 GTP hydrolysis as well as fragmented mitochondria in the axon of the sciatic nerve. Importantly, mutant Rab7 mice further demonstrated preferential sensory behavioral abnormalities and neuropathy, highlighting an important role for mutant Rab7 in driving degeneration of peripheral sensory neurons. Together, this study identifies an important role for mitochondria–lysosome contact sites in the pathogenesis of peripheral neuropathy.Keywords
Funding Information
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R00 NS109252)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (3R00 NS109252-04S2)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R24 NS098523)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R37 NS054154)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R01 NS104295)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NIH HEAL initiative supplement R01 NS104295-01)
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR077691)
This publication has 75 references indexed in Scilit:
- Rab7 Mutants Associated with Charcot-Marie-Tooth Disease Cause Delayed Growth Factor Receptor Transport and Altered Endosomal and Nuclear SignalingJournal of Biological Chemistry, 2013
- Differential Effects of TBC1D15 and Mammalian Vps39 on Rab7 Activation State, Lysosomal Morphology, and Growth Factor DependenceJournal of Biological Chemistry, 2010
- Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2CNature Genetics, 2009
- Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2CNature Genetics, 2009
- Disease mutations in Rab7 result in unregulated nucleotide exchange and inappropriate activationHuman Molecular Genetics, 2009
- Mitofusin 2 tethers endoplasmic reticulum to mitochondriaNature, 2008
- Mitochondria in Neuroplasticity and Neurological DisordersNeuron, 2008
- CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathyBrain, Behavior, and Immunity, 2007
- TBC domain family, member 15 is a novel mammalian Rab GTPase-activating protein with substrate preference for Rab7Biochemical and Biophysical Research Communications, 2005
- A novel RAB7 mutation associated with ulcero‐mutilating neuropathyAnnals of Neurology, 2004